Interestingly, the post-translational regulation of HSD17B4 stability through acetylation at lysine 669—modulated by sirtuin 3 (SIRT3) and CREB-binding protein (CREBBP) [121]—provides a potential mechanism for fine-tuning HSD17B4 activity in the context of cancer. The gene discussed is HSD17B4; the disease is cancer.